Pluristem Therapeutics Inc. (Pluristem) is a clinical-stage biotechnology company. It manufactures and commercializes cell therapy production technologies and products for various diseases by using its three-dimensional (3D) technology platform. The company’s PLacental eXpanded (PLX) cells are mesenchymal-like adherent stromal cells (ASCs), which are derived from full term human placentas. Pluristem provides 3D technology that allows production of its cell therapy products, termed PLacental eXpanded (PLX) cells. Its pipeline products are focused on multiple therapeutic areas and indications including cardiovascular, pulmonary and orthopedic diseases. Some of its partners include United Therapeutics, Cha Bio&Diostech, Berlin-Brandenburg Center for Regenerative Therapies, Center of Therapeutics Angiogenesis, Charite Medical University, Duke University School of Medicine and Franziskus Hospital Berlin, among others. Pluristem is headquartered in Haifa, Israel.

Pluristem Therapeutics Inc. (PSTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

Business Description - A brief description of the company's operations.

Key Employees - A list of the key executives of the company.

Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors - A list of the key competitors of the company.

Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.